Stock YBGJ YUBO INTERNATIONAL BIOTECH LIMITED
Add to a list
To use this feature you must be a member
Log inSign up
PDF Report : Yubo International Biotech Limited

Yubo International Biotech Limited Stock price

Equities

YBGJ

US9883661004

Biotechnology & Medical Research

Delayed OTC Markets
Other stock markets
 10:20:39 2023-11-24 am EST 		Intraday chart for Yubo International Biotech Limited 5-day change 1st Jan Change
0.5153 USD +142.81% +47.65% +442.42%
Nov. 20 Yubo International Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Aug. 11 Yubo International Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions on site

Financials (USD)

Sales 2022 0 Sales 2023 * - Capitalization 11.38 M
Net income 2022 -1,000,000 Net income 2023 * - EV / Sales 2022
116 560 264x
Net Debt 2022 772,279 Net cash position 2023 * - EV / Sales 2023 * -
P/E ratio 2022
-9,36x
P/E ratio 2023 *
Employees 20
Yield 2022
-
Yield 2023 *
-
Free-Float 6.63%
More Fundamentals * Assessed data

Chart Yubo International Biotech Limited

Dynamic Chart

Latest news about Yubo International Biotech Limited

Yubo International Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Yubo International Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Yubo International Biotech Limited Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Yubo International Biotech Limited Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Yubo International Biotech Limited Auditor Raises 'Going Concern' Doubt CI
Yubo International Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Insider Sell: Yubo International Biotech MT
Yubo International Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Yubo International Biotech Limited Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Yubo International Biotech Limited Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Yubo International Biotech Limited Auditor Raises 'Going Concern' Doubt CI
Yubo International Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Yubo International Biotech Limited Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Yubo International Biotech Limited Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Yubo International Biotech Limited Changes Fiscal Year End from the Last Calendar Day of February to December 31 CI
More news

Press releases Yubo International Biotech Limited

YUBO INTERNATIONAL BIOTECH LTD Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K) AQ
YUBO INTERNATIONAL BIOTECH LTD Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K/A) AQ
YUBO INTERNATIONAL BIOTECH LTD Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q) AQ
Yubo International Biotech : STOCK PURCHASE AGREEMENT - Form 8-K PU
YUBO INTERNATIONAL BIOTECH LTD : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K) AQ
More press releases

Quotes and Performance

1 day+142.81%
1 week+47.65%
Current month+47.65%
1 month+47.65%
3 months-5.45%
6 months+492.98%
Current year+442.42%
More quotes

Highs and lows

1 week
0.21
Extreme 0.2122
0.52
1 month
0.21
Extreme 0.2122
0.52
Current year
0.07
Extreme 0.065
0.59
1 year
0.07
Extreme 0.065
0.59
3 years
0.00
Extreme 0
3.98
5 years
0.00
Extreme 0
3.98
10 years
0.00
Extreme 0
3.98
More quotes

Quotes

Date Price Change Volume
23-11-24 0.5153 +142.81% 300

Delayed Quote OTC Markets, November 24, 2023 at 10:20 am EST

More quotes

Company Profile

Yubo International Biotech Ltd, formerly Magna-Lab Inc, is a holding company primarily operating through its subsidiary. The Company focuses on the research and development and application of endometrial stem cells and offers its products and services under the brand VIVCELL. The Company’s product offerings include healthcare products for respiratory system, skincare products, hair care products, healthy beverages and male and female personal care products. The Company also offers stem cell related services including cell testing and health management consulting services.
Sector
Biotechnology & Medical Research
More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

1st Jan change Capi. (M$)
YUBO INTERNATIONAL BIOTECH LIMITED Stock Yubo International Biotech Limited
+442.42% 62 M $
SEAGEN INC. Stock Seagen Inc.
+66.91% 40 404 M $
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+5.11% 38 508 M $
MODERNA, INC. Stock Moderna, Inc.
-55.28% 29 809 M $
LONZA GROUP AG Stock Lonza Group AG
-24.54% 28 695 M $
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+38.32% 22 029 M $
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-32.15% 20 250 M $
CELLTRION, INC. Stock Celltrion, Inc.
+0.75% 17 781 M $
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
-16.82% 10 827 M $
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-9.60% 10 014 M $
Other Biotechnology & Medical Research
  1. Stock
  2. Equities
  3. Stock Yubo International Biotech Limited - OTC Markets
-40% off Black Friday : Our subscriptions help you unlock the best investment opportunities.
Enjoy this offer